Reducing risk of type 2 diabetes (t2d)

Details Reducing risk of type 2 diabetes (t2d) Reducing risk of type 2 diabetes (t2d)

A - Human Necessities

61

K

A61K 31/618 (2006.01) A61K 31/60 (2006.01) A61P 3/00 (2006.01) A61P 3/10 (2006.01) G01N 33/66 (2006.01)

Patent

CA 2685356

This invention relates to methods for reducing chronic subacute inflammatory states associated with obesity and improve glycemia, thereby preventing or delaying the development of type 2 diabetes (T2D) in obese subjects, or subjects with the metabolic syndrome, using non-acetylated forms of salicylate, e.g., salsalate or trilisate.

La présente invention concerne des méthodes pour réduire des états inflammatoires subaigus chroniques associés à l'obésité et pour améliorer la glycémie, prévenant ou retardant ainsi le développement du diabète de type 2 (T2D) chez des sujets obèses ou des sujets atteints d'un syndrome métabolique, grâce à des formes non acétylées de salicylate, par exemple, salsalate ou trilisate.

Affiliated with

Also associated with

Rating

Reducing risk of type 2 diabetes (t2d) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reducing risk of type 2 diabetes (t2d), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reducing risk of type 2 diabetes (t2d) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1593722